BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 18, 2018
View Archived Issues
HIWI2 piRNA binding protein is involved in the pathogenesis of proliferative diabetic retinopathy
Read More
Faron initiates phase I/II study of FP-1305 in advanced solid tumors
Read More
New rat models of ALS better capture human disease pathology
Read More
Characterization of new murine model of polyhydramnios-megalencephaly and symptomatic epilepsy
Read More
SEP-363856 demonstrates safety and efficacy in phase II study in patients with schizophrenia
Read More
Staten Biotechnology, Novo Nordisk enter collaboration and option agreement in hypertriglyceridemia
Read More
Resolvin receptor analogues limit inflammation
Read More
HER mutations can cause ER resistance
Read More
Recombinant measles virus expressing NIS demonstrates antitumor activity in metastatic breast cancer
Read More
Modulation of brain dopamine release by Takeda's GPCR139 agonist TAK-041
Read More
Preclinical data presented for CYT-0851
Read More
CB-103 demonstrates synergistic activity with fulvestrant in ER-positive breast cancer
Read More
Reduced RNA editing links different forms of autism
Read More
Cancer Research Technology patents BCL-6 inhibitors
Read More
Abbisko Therapeutics divulges new CSF-1R inhibitors
Read More
Chengdu Euthare Therapeutics synthesizes CDK4 and CDK6 inhibitors
Read More
Taisho Pharmaceutical discloses bacterial LpxC inhibitors
Read More
Araxes Pharma identifies new mutant KRAS inhibitors
Read More
Kineta and Pfizer collaborate to develop RIG-I agonist immunotherapies for cancer
Read More
Keytruda approved in Europe as adjuvant therapy for adults with resected stage III melanoma
Read More
Topline results presented from phase I study of XCUR-17 in chronic plaque psoriasis
Read More
BeiGene initiates two global phase III studies of tislelizumab
Read More
Phase III obesity registration trial of tesofensine meets primary and secondary endpoints
Read More
Initiation of pivotal phase III program of TWIN for acne vulgaris
Read More
Rakuten Aspyrian opens enrollment in phase III trial of ASP-1929 for head and neck cancer
Read More
China becomes first country to approve roxadustat
Read More
Ayala initiates phase II study of AL-101 in adenoid cystic carcinoma with Notch activated mutations
Read More
Alkahest reports promising data from two phase IIa studies of AKST-4290 in wet AMD
Read More
Ovid Therapeutics presents phase Ib/IIa data for OV-935 in adults with rare epilepsies
Read More
Aclaris offers update on clinical trials of JAK1/3 inhibitors ATI-502 and ATI-501
Read More
Achillion reports update on factor D inhibitor programs
Read More